Thyroid cancer in patients with acromegaly: a case-control study

被引:46
作者
Carvalho dos Santos, Maira Cristina [1 ]
Nascimento, Gilvan Cortes [1 ]
Cortes Nascimento, Ana Giselia [1 ]
Carvalho, Viviane Chaves [2 ]
Cordeiro Lopes, Maria Honorina [1 ]
Montenegro, Renan [3 ]
Montenegro, Renan, Jr. [3 ]
Vilar, Lucio [4 ]
Albano, Monica Fiterman [3 ]
Vasconcelos Alves, Alice Regina [1 ]
Parente, Conceicao Veiga [1 ]
Faria, Manuel dos Santos [1 ]
机构
[1] Fed Univ Maranhao UFMA, Endocrinol Unit, Sao Luis, Maranhao, Brazil
[2] Fed Univ Maranhao UFMA, Pathol Unit, Sao Luis, Maranhao, Brazil
[3] Univ Fed Ceara, Endocrinol Unit, Fortaleza, Ceara, Brazil
[4] Fed Univ Pernambuco UFPE, Endocrinol Unit, Recife, PE, Brazil
关键词
Acromegaly and cancer; IGF-1 and cancer; Thyroid and acromegaly; GH and cancer; 2ND BRAIN-TUMOR; GROWTH-FACTOR-I; PITUITARY-ADENOMA; CONSERVATIVE SURGERY; RISK; INSULIN; RADIOTHERAPY; PREVALENCE; PATHOGENESIS; MULTICENTER;
D O I
10.1007/s11102-012-0383-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several studies have associated acromegaly with an increased risk of benign and malignant tumors. While simple and multinodular goiters are common findings in acromegaly, the prevalence of thyroid cancer is uncertain. The objective of this study was to estimate the prevalence of thyroid cancer in a series of acromegalic patients from three hospitals in northeast of Brazil. The methodology used included morphological, cytological and histological thyroid analysis of acromegalic patients and volunteers over 18 years, matched for age and sex and with nodule (s) a parts per thousand yen1 cm. The subjects of this study were 124 acromegalic patients, including 76 females (61.3%) and 48 men (38.7%), with a mean age 45.1 years. Results of the study showed that thyroid ultrasonography was normal in 31 cases (25%), 25 had diffuse goiter (20.1%), 67 had nodules (54%) and one agenesis of the right lobe (0.8%). Thirty-six patients underwent fine needle aspiration biopsy (FNAB) of their nodules and 9 cases of papillary cancer were found (7.2%). The control group consisted of 263 subjects, 156 females (59.3%) and 107 males (40.7%), mean age 44.7 years. In ultrasound assessment, 96 had nodules (36.5%). Of these, 13 were punctured and 2 cases of papillary carcinoma were found (0.7%). These results gave an odds ratio of 10.21 (p = 0.0011, 95% CI 2.17 to 48.01). These findings demonstrate an increased prevalence of thyroid cancer, statistically significant when compared to our control group. Thus, it is suggested that acromegalic patients should be routinely submitted to thyroid ultrasound evaluation, followed by FNAB of nodules when indicated.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 38 条
[1]   Mortality following pituitary radiotherapy [J].
Ayuk, John ;
Stewart, Paul M. .
PITUITARY, 2009, 12 (01) :35-39
[2]   Acromegaly and cancer risk: a cohort study in Sweden and Denmark [J].
Baris, D ;
Gridley, G ;
Ron, E ;
Weiderpass, E ;
Mellemkjaer, L ;
Ekbom, A ;
Olsen, JH ;
Baron, JA ;
Fraumeni, JF .
CANCER CAUSES & CONTROL, 2002, 13 (05) :395-400
[3]   Changes in the expression of the peroxisome proliferator-activated receptor γ gene in the colonic polyps and colonic mucosa of acromegalic patients [J].
Bogazzi, F ;
Ultimieri, F ;
Raggi, F ;
Russo, D ;
Viacava, P ;
Cecchetti, D ;
Costa, A ;
Brogioni, S ;
Cosci, C ;
Gasperi, M ;
Bartalena, L ;
Martino, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3938-3942
[4]  
BONISCHNETZLER M, 1990, MOL ENDOCRINOL, V4, P1320
[5]   RISK OF 2ND BRAIN-TUMOR AFTER CONSERVATIVE SURGERY AND RADIOTHERAPY FOR PITUITARY-ADENOMA [J].
BRADA, M ;
FORD, D ;
ASHLEY, S ;
BLISS, JM ;
CROWLEY, S ;
MASON, M ;
RAJAN, B ;
TRAISH, D .
BRITISH MEDICAL JOURNAL, 1992, 304 (6838) :1343-1346
[6]  
Cats A, 1996, CANCER RES, V56, P523
[7]   The thyroid gland in acromegaly: An ultrasonographic study [J].
Cheung, NW ;
Boyages, SC .
CLINICAL ENDOCRINOLOGY, 1997, 46 (05) :545-549
[8]   Growth hormone, the insulin-like growth factor axis, insulin and cancer risk [J].
Clayton, Peter E. ;
Banerjee, Indraneel ;
Murray, Philip G. ;
Renehan, Andrew G. .
NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (01) :11-24
[9]  
Coeli Cláudia M., 2005, Arq Bras Endocrinol Metab, V49, P503, DOI 10.1590/S0004-27302005000400006
[10]   Does the GH-IGF axis play a role in cancer pathogenesis? [J].
Cohen, P ;
Clemmons, DR ;
Rosenfeld, RG .
GROWTH HORMONE & IGF RESEARCH, 2000, 10 (06) :297-305